{
    "clinical_study": {
        "@rank": "134505", 
        "arm_group": [
            {
                "arm_group_label": "Blackberry", 
                "arm_group_type": "Experimental", 
                "description": "Participants will consume blackberries twice/day as part of a 1-week controlled diet."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Other", 
                "description": "Participants will consume jello twice/day as part of a 1-week controlled diet."
            }
        ], 
        "brief_summary": {
            "textblock": "Studies in animals have suggested that berry preparations or anthocyanin-rich berry extracts\n      can reduce body fatness. Previous studies with tea catechins, which belong to the flavonoid\n      class of chemicals as do anthocyanins, suggest that these compounds can alter fat oxidation,\n      and this may be the mechanism by which body fatness is influenced by anthocyanin intake.\n      Well-controlled studies in humans are lacking."
        }, 
        "brief_title": "Blackberry Polyphenol Intake and Fuel Management", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Fuel Management", 
        "eligibility": {
            "criteria": {
                "textblock": "Exclusion Criteria:\n\n          -  Younger than 25 years old or older than 75 years old\n\n          -  Female\n\n          -  Use of blood-thinning medications such as Coumadin (warfarin), Dicumarol (dicumarol),\n             or Miradon (anisinidione)\n\n          -  Presence of any gastrointestinal disease, metabolic disease, or malabsorption\n             syndromes that may interfere with the study goals\n\n          -  Have been pregnant during the previous 12 months, are currently pregnant or\n             lactating, or plan to become pregnant during the study\n\n          -  Type 2 diabetes requiring the use of oral antidiabetic agents or insulin\n\n          -  Fasting triglycerides greater than 300 mg/dL\n\n          -  Fasting glucose greater than 126 mg/dL\n\n          -  History of eating disorders or other dietary patterns which are not consistent with\n             the dietary intervention (e.g., vegetarians, very low fat diets, high protein diets)\n\n          -  Use of prescription or over-the-counter antiobesity medications or supplements (e.g.,\n             phenylpropanalamine, ephedrine, caffeine) during and for at least 6 months prior to\n             the start of the study or a history of a surgical intervention for obesity\n\n          -  Active cardiovascular disease (such as a heart attack or procedure within the past\n             three months or participation in a cardiac rehabilitation program within the last\n             three months, stroke, or history/treatment for transient ischemic attacks in the past\n             three months, or documented history of pulmonary embolus in the past six months).\n\n          -  Use of any tobacco products in past 3 months\n\n          -  Use of oral or IV antibiotics during the month preceding the study\n\n          -  Unwillingness to abstain from herbal supplements for two weeks prior to the study and\n             during the study\n\n          -  Known (self-reported) allergy or adverse reaction to blackberries\n\n          -  Unable or unwilling to give informed consent or communicate with study staff\n\n          -  Self-report of alcohol or substance abuse within the past twelve months and/or\n             current acute treatment or rehabilitation program for these problems (Long-term\n             participation in Alcoholics Anonymous is not an exclusion)\n\n          -  Other medical, psychiatric, or behavioral factors that in the judgment of the\n             Principal Investigator may interfere with study participation or the ability to\n             follow the intervention protocol"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01932879", 
            "org_study_id": "HS44"
        }, 
        "intervention": [
            {
                "arm_group_label": "Blackberry", 
                "description": "Participants will be fed a higher fat, typical American diet for two 1-week periods. Participants must consume only and all food provided during the intervention periods.", 
                "intervention_name": "Blackberry", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Control", 
                "intervention_name": "Jello", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Beltsville", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20705"
                }, 
                "name": "USDA Beltsville Human Nutrition Research Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Participants will stay in a room calorimeter for 23.5 hours.", 
            "measure": "Substrate oxidation", 
            "safety_issue": "No", 
            "time_frame": "23.5 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01932879"
        }, 
        "responsible_party": {
            "investigator_affiliation": "USDA Beltsville Human Nutrition Research Center", 
            "investigator_full_name": "Janet Novotny", 
            "investigator_title": "Research Physiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Blood will be collected at the end of each diet period, at the following times before and after breakfast:  -15, 0, 30, 60, 90, 120, 180, 240 minutes.", 
            "measure": "Glucose tolerance test", 
            "safety_issue": "No", 
            "time_frame": "-15, 0, 30, 60, 90, 120, 180, 240 minutes"
        }, 
        "source": "USDA Beltsville Human Nutrition Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "USDA Beltsville Human Nutrition Research Center", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}